BEWICK CRESCENT SURGERY
27 BEWICK CRESCENT, NEWTON AYCLIFFE
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 94 | 103 | 91.3% | |
| CKD 4 | 2008 | 143 | 171 | 83.6% | |
| CKD 5 | 2009 | 14 | 15 | 93.3% | |
| CKD 5 | 2010 | 27 | 31 | 87.1% | |
| CKD 5 | 2011 | 24 | 28 | 85.7% | |
| CKD 5 | 2012 | 22 | 26 | 84.6% | |
| CKD 5 | 2013 | 19 | 23 | 82.6% | |
| CKD003 | 2014 | 17 | 18 | 94.4% | |
| CKD003 | 2015 | 19 | 22 | 86.4% | |
| NM84 | 2016 | 16 | 22 | 72.7% | |
| NM84 | 2020 | 7 | 14 | 50.0% | |
| NM84 | 2022 | 13 | 18 | 72.2% | |
| NM84 | 2023 | 15 | 19 | 78.9% |
